REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Adipharm EAD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Adipharm EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

adipharm ead is a Bulgarian pharmaceutical company. The company specializes in the development, production, and sale of medicinal products and nutritional supplements. adipharm ead's manufacturing plant is equipped with modern high-tech equipment, and the company is constantly investing in expanding and renewing its production capabilities. The company's activity is in three main directions, and it offers options for joint contractual partnership to local or international companies.

Headquarters
Simeonovsko Shose 130
Sofia; Sofia - city; Postal Code: 1700

Contact Details: Purchase the Adipharm EAD report to view the information.

Website: http://www.adipharm.com

Basic Information
Total Employees:
Purchase the Adipharm EAD report to view the information.
Outstanding Shares:
Purchase the Adipharm EAD report to view the information.
Registered Capital:
Purchase the Adipharm EAD report to view the information.
Financial Auditors:
Purchase the Adipharm EAD report to view the information.
Incorporation Date:
June 24, 1994
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Adipharm EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
43.28%▲
Total operating revenue
49.55%▲
Net Profit (Loss) for the Period
84.68%▲
Total assets
26.94%▲
Total equity
29.92%▲
Net Profit Margin
6.27%▲
Return on Equity (ROE)
6.83%▲
Debt to Equity Ratio
-0.19%▼
Quick Ratio
5.91%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo